Lynx Analytics introduced Lumen, a specialised Agentic AI framework designed to assist pharmaceutical and biotech organizations generate strategic, decision-ready insights from complicated scientific and business info.
Constructed particularly for all times sciences workflows, Lumen permits corporations to deploy AI brokers throughout a variety of real-world use circumstances — from quickly distilling prolonged medical or market analysis paperwork, to producing dynamic HCP personas and customized engagement methods, to powering natural-language analytics that specify drivers behind forecast shifts or market efficiency. The framework brings gathered finest practices from a number of Agentic AI deployments throughout world pharma corporations.
One of many first real-world purposes constructed on Lumen is IlluminAI — a custom-made decision-support answer developed in collaboration with the Worldwide Oncology crew at AstraZeneca.
Additionally Learn: AiThority Interview That includes: Pranav Nambiar, Senior Vice President of AI/ML and PaaS at DigitalOcean
“The introduction of the IlluminAI assistant at AstraZeneca has streamlined how we strategy model launch planning. Our groups can ask natural-language questions on forecast drivers and obtain insights grounded in affected person forecast fashions and income knowledge. IlluminAI is now embedded in planning cycles throughout Worldwide Markets. We stay up for persevering with our partnership with Lynx Analytics to additional develop IlluminAI.” mentioned Christos Georgiou, Oncology Launch & Enterprise Excellence Director, Worldwide Markets at AstraZeneca.
Ankit Agrawal, Director of Consumer Engagement at Lynx Analytics, added: “Lumen is the muse for Lynx’s subsequent era of Agentic AI in pharma, already deployed throughout precedence business and medical use circumstances. At AstraZeneca, IlluminAI places this into follow for the Worldwide Oncology crew, the place brokers join affected person forecast fashions and income knowledge to pinpoint the important thing drivers and assumptions behind every forecast, defined in easy, easy-to-understand language”
Lumen permits decision-support brokers reminiscent of campaign-planning copilots that forecast ROI and generate focused content material; patient-support brokers that ship compliant, 24/7 medical info; and clinical-trial intelligence brokers that floor related insights and assist groups monitor research challenges in actual time. All insights embrace linked citations for transparency, giving groups audit-ready proof behind every suggestion.
Lumen is now out there to pharmaceutical and life sciences organizations looking for to raise strategic planning, speed up evaluation, and deploy accountable AI at scale.
Additionally Learn: The Finish Of Serendipity: What Occurs When AI Predicts Each Selection?
[To share your insights with us, please write to psen@itechseries.com ]
